InvestorsHub Logo
Followers 5
Posts 809
Boards Moderated 0
Alias Born 08/30/2017

Re: None

Thursday, 08/08/2019 9:30:55 AM

Thursday, August 08, 2019 9:30:55 AM

Post# of 1742
Great News is out. Receipt of final meeting minutes

Evoke Pharma Inc. to resubmit New Drug Application (NDA) for Gimoti. The company also release the ER today. Company stated it has $7.2 million in cash to last until 2nd quarter of 2020. The company addressed the 2 concern in the CRL and the FDA is satisfied.

It is a Go for Gimoti, it will be the second drug on the market to treat Gastroparesis disease. The only drug on the 3 to 4 billion dollar market is Reglan and it is taking orally.

Gimoti is clear for a go for resubmission of NDA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News